摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-甲基苯基)噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮 | 500112-74-3

中文名称
5-(4-甲基苯基)噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮
中文别名
——
英文名称
5-(4'-tolyl)thiazolo[2.3-c][1.2.4]triazole-3-thiol
英文别名
5-(4-Methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazole-3-thiol;5-(4-methylphenyl)-2H-[1,3]thiazolo[2,3-c][1,2,4]triazole-3-thione
5-(4-甲基苯基)噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮化学式
CAS
500112-74-3
化学式
C11H9N3S2
mdl
MFCD06254379
分子量
247.345
InChiKey
LNDYWRMGFKFDTC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194-195℃

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    85
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:e538ad7c4daf60bd2c42d4a5ad7ecaa2
查看

反应信息

  • 作为反应物:
    描述:
    5-(4-甲基苯基)噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮碘甲烷potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 以99%的产率得到3-(methylthio)-5-(4'-tolyl)thiazolo[2.3-c][1.2.4]triazole
    参考文献:
    名称:
    Crystal Structures and Structure–Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors
    摘要:
    Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure activity relationships (SAR) at the pocket-B of IDO I, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDOI activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.
    DOI:
    10.1021/ml500247w
点击查看最新优质反应信息

文献信息

  • Crystal Structures and Structure–Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors
    作者:Shingo Tojo、Tetsuya Kohno、Tomoyuki Tanaka、Seiji Kamioka、Yosuke Ota、Takayuki Ishii、Keiko Kamimoto、Shigehiro Asano、Yoshiaki Isobe
    DOI:10.1021/ml500247w
    日期:2014.10.9
    Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure activity relationships (SAR) at the pocket-B of IDO I, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDOI activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.
查看更多

同类化合物

5-(4-甲基苯基)噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮 5-(4-氯苯基)-噻唑并[2,3-c]-1,2,4-三唑-3(2H)-硫酮 1-(6-甲基噻唑并[3,2-B][1,2,4]三唑-5-基)乙酮 1-(6-甲基[1,3]噻唑并[3,2-B] [1,2,4]三唑-5-基)乙醇 5-(4-bromophenyl)-6-methylthiazolo[3,2-b][1,2,4]triazole 6-methyl-5-m-tolylthiazolo[3,2-b][1,2,4]triazole 6-methyl-5-o-tolylthiazolo[3,2-b][1,2,4]triazole (Z)-5-(4-(diethylamino)benzylidene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (Z)-5-(furan-2-ylmethylene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (Z)-5-(2-fluorobenzylidene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (Z)-5-(3,4-dimethoxybenzylidene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (Z)-5-(thiophen-2-y-lmethylene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (Z)-5-(2-(allyloxy)benzylidene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one 5-(p-bromophenyl)-3-(2-thienyl)thiazolo[2,3-c]-s-triazole (Z)-5-(2-methoxybenzylidene)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one 3-ethoxycarbonyl-6-methylthiazolo<3,2-c><1,2,3>triazole 6-((4-Chlorophenyl)methylene)-3-methylthiazolo(2,3-c)-1,2,4-triazol-5(6H)-one 6-((4-(Dimethylamino)phenyl)methylene)-3-methylthiazolo(2,3-c)-1,2,4-triazol-5(6H)-one 6-((4-Methoxyphenyl)methylene)-3-methylthiazolo(2,3-c)-1,2,4-triazol-5(6H)-one 6-((4-(Dimethylamino)phenyl)methylene)thiazolo(2,3-c)-1,2,4-triazol-5(6H)-one N-(6-methyl-thiazolo[3,2-b][1,2,4]triazol-2-yl)-diacetamide 5-(4-chlorophenyl)-6-methylthiazolo[3,2-b][1,2,4]triazole (6-methyl[1,3]thiazolo[3,2-b][1,2,4]triazol-5-yl)methanol 5-phenyl-thiazolo[2,3-c][1,2,4]triazol-3-ylamine 3-ethyl-5-phenylthiazolo[2,3-c][1,2,4]triazole <2-Ethoxy-2-(6-methylthiazolo<3,2-b><1,2,4>triazol-5-yl)ethyl>phosphonsaeure-diethylester <(E)-2-(6-Methylthiazolo<3,2-b><1,2,4>triazol-5-yl)ethenyl>phosphonsaeure-diethylester 5-(3-methoxyphenyl)-6-methylthiazolo[3,2-b]-1,2,4-triazole 5-(3-methoxyphenyl)-6-(p-tolyl)thiazolo[3,2-b][1,2,4]triazole 5-(3-methoxyphenyl)-6-(4-methoxyphenyl)thiazolo[3,2-b][1,2,4]triazole 6-Trimethylsilyltriazolothiazole 2-benzyl-6-[phenyl(piperidin-1-yl)methyl]thiazolo[3,2-b][1,2,4]triazol-5-ol (E)-2-benzyl-6-benzylidenethiazolo[3,2-b][1,2,4]triazol-5(6H)-one 6-((4-(Diethylamino)phenyl)methylene)-3-methylthiazolo(2,3-c)-1,2,4-triazol-5(6H)-one 6-Benzylidenethiazolo[2,3-c][1,2,4]triazol-5(6H)-one 6-methylthiazolo<2,3-c><1,2,3>triazole 1-[6-Methyl-2-(trifluoromethyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-5-yl]ethanone 6-(4-bromophenyl)-5-(3-fluorophenyl)thiazolo[3,2-b]-1,2,4-triazole 5-(3-fluorophenyl)-6-methylthiazolo[3,2-b]-1,2,4-triazole 5-(3-fluorophenyl)-6-p-tolylthiazolo[3,2-b]-1,2,4-triazole 6-[1-Phenyl-meth-(Z)-ylidene]-thiazolo[2,3-c][1,2,4]triazol-5-one N,N-bis([1,3]thiazolo[3,2-b][1,2,4]triazol-6-ylmethyl)cyclohexanamine;hydron;chloride 6-(1H-imidazol-3-ium-3-ylmethyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole;chloride 3-methylsulfanyl-5-phenylthiazolo[2,3-c][1,2,4]triazole 5-[(2,4-Dichlorophenyl)methylidene]-2-(furan-2-yl)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one 5-[(4-Bromophenyl)methylidene]-2-[2-(4-chlorophenyl)ethenyl][1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one 2-[2-(4-Chlorophenyl)ethenyl]-5-[(5-methylfuran-2-yl)methylidene][1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one 2-[2-(4-Chlorophenyl)ethenyl]-5-{[4-(hexyloxy)-3-methoxyphenyl]methylidene}[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one (+/-)-1-(6-methyl[1,3]thiazolo[3,2-b][1,2,4]triazol-5-yl)ethyl cyclobutylcarbamate [1,3]Thiazolo[3,2-b][1,2,4]triazole